Chloe Thompson-Peach
7PUBLICATIONS
58CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 02, 2026
Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.Chloe A L Thompson-Peach, Daniel Thomas, Mara Dottore
|Mar 08, 2024
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.Lih En Hong, Mihir D Wechalekar, Monika Kutyna
|Nov 10, 2022
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.Daniel Thomas, Manhong Wu, Yusuke Nakauchi
|May 13, 2022
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.Mahmoud A Bassal, Saumya E Samaraweera, Kelly Lim
|Apr 20, 2022
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.Alexander C Lewis, Victoria S Pope, Melinda N Tea
|Feb 14, 2022
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody.Denis Tvorogov, Chloe A L Thompson-Peach, Johannes Foßelteder
Pageof 2
Frequent Collaborators
6 joint publications
Kelly Lim
5 joint publications
Nirmal Robinson
5 joint publications
Stuart Pitson
4 joint publications
Daniel Thomas
4 joint publications
Richard J D'Andrea
4 joint publications
Anna L Brown
3 joint publications
Saumya E Samaraweera
3 joint publications
Ravindra Majeti
3 joint publications
Andreas Reinisch
2 joint publications
Johannes Foßelteder
